» Articles » PMID: 38202216

Atrial Fibrillation Ablation with a Novel Fully 3D-Mapping-Integrated Multi-Electrode Radiofrequency Balloon Catheter

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jan 11
PMID 38202216
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary vein isolation (PVI), as the cornerstone of atrial fibrillation (AF) ablation, has emerged a widely used therapy for patients suffering from AF. To improve PVI efficiency, single-shot catheters (SSCs) have been developed. Regrettably, SSCs are not integrated into 3D-mapping technology. In that regard, a novel radiofrequency balloon catheter (RFBC, Heliostar, Biosense Webster) with full integration into 3D-mapping technology has been developed. The aim of this study was to assess operative and follow-up outcomes of the RFBC in AF patients. In this monocentric prospective registry, patients with a first-time PVI using the RFBC were included. Follow-up visits were scheduled 3, 6, 12 and 24 months after ablation and in case of symptoms. A total of 171 patients (36.8% female) were included, with a mean age of 68.5 ± 10.2 years. Among them, 63 patients (36.8%) presented with persistent AF. Notably, no major periprocedural complications were observed. The mean follow-up period was 287 ± 157 days. In the Kaplan-Meier analysis, the estimated recurrence-free survival after 12 months was 81.8%. Based on our data, PVI with the fully 3D-mapping-integrated RFBC seems to be safe and effective and to have a favorable 12-month outcome in patients with paroxysmal and persistent AF.

Citing Articles

Comparative Analysis of Real-World Clinical Outcomes of a Novel Pulsed Field Ablation System for Pulmonary Vein Isolation: The Prospective CIRCLE-PVI Study.

Katov L, Teumer Y, Bothner C, Rottbauer W, Weinmann-Emhardt K J Clin Med. 2024; 13(23).

PMID: 39685499 PMC: 11642190. DOI: 10.3390/jcm13237040.


Comparison between a Novel Radiofrequency-Balloon and a Standard Cryo-Balloon in Pulmonary Vein Isolation: A Propensity-Score-Matched Analysis.

Teumer Y, Miesbichler C, Katov L, Mayer B, Rottbauer W, Bothner C J Clin Med. 2024; 13(4).

PMID: 38398276 PMC: 10889331. DOI: 10.3390/jcm13040963.

References
1.
Rattka M, Pott A, Kuhberger A, Weinmann K, Scharnbeck D, Stephan T . Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients. Europace. 2020; 22(9):1328-1336. PMC: 7478318. DOI: 10.1093/europace/euaa101. View

2.
My I, Bordignon S, Butt M, Rottner L, Marc L, Moser F . Novel Radiofrequency Balloon Catheter - Impact of Ablation Parameters on Single-Shot Isolation. Circ J. 2023; 87(7):950-956. DOI: 10.1253/circj.CJ-23-0220. View

3.
Heeger C, Sohns C, Pott A, Metzner A, Inaba O, Straube F . Phrenic Nerve Injury During Cryoballoon-Based Pulmonary Vein Isolation: Results of the Worldwide YETI Registry. Circ Arrhythm Electrophysiol. 2021; 15(1):e010516. PMC: 8772436. DOI: 10.1161/CIRCEP.121.010516. View

4.
Heeger C, Pott A, Sohns C, Riesinger L, Sommer P, Gasperetti A . Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety-ANTARCTICA study. Europace. 2022; 24(12):1917-1925. PMC: 9733956. DOI: 10.1093/europace/euac148. View

5.
Pott A, Jack S, Schweizer C, Baumhardt M, Stephan T, Rattka M . Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation. ESC Heart Fail. 2020; 7(5):2258-2267. PMC: 7524096. DOI: 10.1002/ehf2.12735. View